Diabetic peripheral neuropathy in patients with type 2 diabetes mellitus. Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with type 2 diabetes with peripheral diabetic neuropathy in the nerve-muscle strip. Consent to participate in the study. Visit to a cardiologist and issuance of a physical activity permit.
Exclusion criteria
Exclusion criteria: Presence of diabetic ulcer Charcot foot and amputation Suffering from musculoskeletal disorders that limit cycling Presence of cognitive disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood sugar (FBS). Timepoint: At baseline (before intervention) and after 4 weeks of intervention. Method of measurement: Fasting blood glucose measurement via blood test.;Mean change in Neuropathy Symptom Score (NSS) using the PROM questionnaire. Timepoint: At baseline (before intervention) and after 4 weeks of intervention. Method of measurement: Assessment of neuropathy symptoms using the PROM questionnaire.;Mean change in Timed Up and Go (TUG) test time. Timepoint: At baseline (before intervention) and after 4 weeks of intervention. Method of measurement: Timed Up and Go (TUG) test administered by a physician.;Mean change in balance score using a stabilometer. Timepoint: At baseline (before intervention) and after 4 weeks of intervention. Method of measurement: Balance measurement using a stabilometer device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Mazandaran University of Medical Sciences